Logo image of 1ORCL.MI

ORACLE CORP (1ORCL.MI) Stock Fundamental Analysis

BIT:1ORCL - Euronext Milan - US68389X1054 - Common Stock - Currency: EUR

205.35  -4.85 (-2.31%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 1ORCL. 1ORCL was compared to 100 industry peers in the Software industry. 1ORCL has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ORCL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1ORCL had positive earnings in the past year.
In the past year 1ORCL had a positive cash flow from operations.
In the past 5 years 1ORCL has always been profitable.
In the past 5 years 1ORCL always reported a positive cash flow from operatings.
1ORCL.MI Yearly Net Income VS EBIT VS OCF VS FCF1ORCL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

1.2 Ratios

1ORCL has a better Return On Assets (7.39%) than 77.00% of its industry peers.
1ORCL has a Return On Equity of 60.84%. This is amongst the best in the industry. 1ORCL outperforms 98.00% of its industry peers.
The Return On Invested Capital of 1ORCL (11.77%) is better than 85.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ORCL is in line with the industry average of 10.36%.
Industry RankSector Rank
ROA 7.39%
ROE 60.84%
ROIC 11.77%
ROA(3y)7.05%
ROA(5y)7.55%
ROE(3y)324.52%
ROE(5y)N/A
ROIC(3y)11.91%
ROIC(5y)12.88%
1ORCL.MI Yearly ROA, ROE, ROIC1ORCL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 400 600

1.3 Margins

1ORCL has a Profit Margin of 21.68%. This is amongst the best in the industry. 1ORCL outperforms 90.00% of its industry peers.
In the last couple of years the Profit Margin of 1ORCL has declined.
1ORCL has a better Operating Margin (31.45%) than 94.00% of its industry peers.
1ORCL's Operating Margin has declined in the last couple of years.
1ORCL has a Gross Margin (70.51%) which is comparable to the rest of the industry.
1ORCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 31.45%
PM (TTM) 21.68%
GM 70.51%
OM growth 3Y-5.53%
OM growth 5Y-2.86%
PM growth 3Y11.06%
PM growth 5Y-3.53%
GM growth 3Y-3.75%
GM growth 5Y-2.42%
1ORCL.MI Yearly Profit, Operating, Gross Margins1ORCL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

2

2. Health

2.1 Basic Checks

1ORCL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 1ORCL has been increased compared to 1 year ago.
The number of shares outstanding for 1ORCL has been reduced compared to 5 years ago.
The debt/assets ratio for 1ORCL has been reduced compared to a year ago.
1ORCL.MI Yearly Shares Outstanding1ORCL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
1ORCL.MI Yearly Total Debt VS Total Assets1ORCL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

An Altman-Z score of 3.26 indicates that 1ORCL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.26, 1ORCL is in line with its industry, outperforming 53.00% of the companies in the same industry.
1ORCL has a Debt/Equity ratio of 4.17. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 4.17, 1ORCL is not doing good in the industry: 84.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF N/A
Altman-Z 3.26
ROIC/WACC1.09
WACC10.81%
1ORCL.MI Yearly LT Debt VS Equity VS FCF1ORCL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

1ORCL has a Current Ratio of 0.75. This is a bad value and indicates that 1ORCL is not financially healthy enough and could expect problems in meeting its short term obligations.
1ORCL has a worse Current ratio (0.75) than 78.00% of its industry peers.
A Quick Ratio of 0.75 indicates that 1ORCL may have some problems paying its short term obligations.
1ORCL has a Quick ratio of 0.75. This is in the lower half of the industry: 1ORCL underperforms 78.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
1ORCL.MI Yearly Current Assets VS Current Liabilites1ORCL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

6

3. Growth

3.1 Past

1ORCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.26%, which is quite good.
1ORCL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.22% yearly.
Looking at the last year, 1ORCL shows a quite strong growth in Revenue. The Revenue has grown by 8.38% in the last year.
Measured over the past years, 1ORCL shows a small growth in Revenue. The Revenue has been growing by 8.00% on average per year.
EPS 1Y (TTM)8.26%
EPS 3Y7.09%
EPS 5Y9.22%
EPS Q2Q%4.29%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y10.59%
Revenue growth 5Y8%
Sales Q2Q%11.31%

3.2 Future

Based on estimates for the next years, 1ORCL will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.67% on average per year.
Based on estimates for the next years, 1ORCL will show a quite strong growth in Revenue. The Revenue will grow by 16.38% on average per year.
EPS Next Y14.72%
EPS Next 2Y17.8%
EPS Next 3Y19.5%
EPS Next 5Y19.67%
Revenue Next Year17.03%
Revenue Next 2Y18.15%
Revenue Next 3Y17.96%
Revenue Next 5Y16.38%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ORCL.MI Yearly Revenue VS Estimates1ORCL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B
1ORCL.MI Yearly EPS VS Estimates1ORCL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

2

4. Valuation

4.1 Price/Earnings Ratio

1ORCL is valuated quite expensively with a Price/Earnings ratio of 40.03.
Based on the Price/Earnings ratio, 1ORCL is valued a bit cheaper than 70.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.35. 1ORCL is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 34.90 indicates a quite expensive valuation of 1ORCL.
1ORCL's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of 1ORCL to the average of the S&P500 Index (37.54), we can say 1ORCL is valued inline with the index average.
Industry RankSector Rank
PE 40.03
Fwd PE 34.9
1ORCL.MI Price Earnings VS Forward Price Earnings1ORCL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

1ORCL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.33
1ORCL.MI Per share data1ORCL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ORCL does not grow enough to justify the current Price/Earnings ratio.
1ORCL has a very decent profitability rating, which may justify a higher PE ratio.
1ORCL's earnings are expected to grow with 19.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.72
PEG (5Y)4.34
EPS Next 2Y17.8%
EPS Next 3Y19.5%

6

5. Dividend

5.1 Amount

1ORCL has a yearly dividend return of 0.80%, which is pretty low.
1ORCL's Dividend Yield is rather good when compared to the industry average which is at 2.09. 1ORCL pays more dividend than 81.00% of the companies in the same industry.
With a Dividend Yield of 0.80, 1ORCL pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

On average, the dividend of 1ORCL grows each year by 12.29%, which is quite nice.
Dividend Growth(5Y)12.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

38.12% of the earnings are spent on dividend by 1ORCL. This is a low number and sustainable payout ratio.
The dividend of 1ORCL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.12%
EPS Next 2Y17.8%
EPS Next 3Y19.5%
1ORCL.MI Yearly Income VS Free CF VS Dividend1ORCL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
1ORCL.MI Dividend Payout.1ORCL.MI Dividend Payout, showing the Payout Ratio.1ORCL.MI Dividend Payout.PayoutRetained Earnings

ORACLE CORP

BIT:1ORCL (7/24/2025, 7:00:00 PM)

205.35

-4.85 (-2.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-11 2025-06-11/amc
Earnings (Next)09-08 2025-09-08/amc
Inst Owners44.69%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap576.79B
Analysts78.7
Price Target195.72 (-4.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend1.46
Dividend Growth(5Y)12.29%
DP38.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.04%
Min EPS beat(2)-3.45%
Max EPS beat(2)1.38%
EPS beat(4)2
Avg EPS beat(4)-0.46%
Min EPS beat(4)-3.45%
Max EPS beat(4)2.86%
EPS beat(8)4
Avg EPS beat(8)-0.41%
EPS beat(12)6
Avg EPS beat(12)-0.45%
EPS beat(16)9
Avg EPS beat(16)0.61%
Revenue beat(2)1
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-3.73%
Max Revenue beat(2)0.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.86%
Min Revenue beat(4)-3.73%
Max Revenue beat(4)0.02%
Revenue beat(8)1
Avg Revenue beat(8)-2.27%
Revenue beat(12)1
Avg Revenue beat(12)-1.98%
Revenue beat(16)1
Avg Revenue beat(16)-1.81%
PT rev (1m)22.62%
PT rev (3m)12.11%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)0.08%
EPS NY rev (1m)0.18%
EPS NY rev (3m)1.52%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)2.36%
Valuation
Industry RankSector Rank
PE 40.03
Fwd PE 34.9
P/S 11.81
P/FCF N/A
P/OCF 32.57
P/B 33.16
P/tB N/A
EV/EBITDA 31.33
EPS(TTM)5.13
EY2.5%
EPS(NY)5.88
Fwd EY2.87%
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)6.31
OCFY3.07%
SpS17.38
BVpS6.19
TBVpS-14.03
PEG (NY)2.72
PEG (5Y)4.34
Profitability
Industry RankSector Rank
ROA 7.39%
ROE 60.84%
ROCE 13.3%
ROIC 11.77%
ROICexc 12.83%
ROICexgc 27.68%
OM 31.45%
PM (TTM) 21.68%
GM 70.51%
FCFM N/A
ROA(3y)7.05%
ROA(5y)7.55%
ROE(3y)324.52%
ROE(5y)N/A
ROIC(3y)11.91%
ROIC(5y)12.88%
ROICexc(3y)13.1%
ROICexc(5y)16.61%
ROICexgc(3y)39.23%
ROICexgc(5y)55.84%
ROCE(3y)13.45%
ROCE(5y)14.55%
ROICexcg growth 3Y-23.53%
ROICexcg growth 5Y-29.92%
ROICexc growth 3Y-14.65%
ROICexc growth 5Y-10.84%
OM growth 3Y-5.53%
OM growth 5Y-2.86%
PM growth 3Y11.06%
PM growth 5Y-3.53%
GM growth 3Y-3.75%
GM growth 5Y-2.42%
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 4.17
Debt/FCF N/A
Debt/EBITDA 3.52
Cap/Depr 343.62%
Cap/Sales 36.96%
Interest Coverage 5.35
Cash Conversion 85.94%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 3.26
F-Score6
WACC10.81%
ROIC/WACC1.09
Cap/Depr(3y)199.27%
Cap/Depr(5y)163.1%
Cap/Sales(3y)22.44%
Cap/Sales(5y)16.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.26%
EPS 3Y7.09%
EPS 5Y9.22%
EPS Q2Q%4.29%
EPS Next Y14.72%
EPS Next 2Y17.8%
EPS Next 3Y19.5%
EPS Next 5Y19.67%
Revenue 1Y (TTM)8.38%
Revenue growth 3Y10.59%
Revenue growth 5Y8%
Sales Q2Q%11.31%
Revenue Next Year17.03%
Revenue Next 2Y18.15%
Revenue Next 3Y17.96%
Revenue Next 5Y16.38%
EBIT growth 1Y12.33%
EBIT growth 3Y4.48%
EBIT growth 5Y4.91%
EBIT Next Year37.99%
EBIT Next 3Y27.05%
EBIT Next 5Y25.21%
FCF growth 1Y-103.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.5%
OCF growth 3Y29.72%
OCF growth 5Y9.64%